Skip to main content
SpringerLink
Log in

Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

We previously demonstrated that berberine (BBR) inhibits cell proliferation and induces apoptosis in a human uterine leiomyoma (UtLM) cell line but does not demonstrate a significant cytotoxic effect in a normal human uterine smooth muscle (UtSM) cell line. However, the mechanisms of this inhibition are unclear. Of note, cyclooxygenase 2 (COX2) and pituitary tumor-transforming gene 1 (PTTG1) are overexpressed in human uterine leiomyomata and are involved in the pathogenesis of uterine fibroids (UFs). We found that COX2 and PTTG1 were overexpressed in UtLM and that BBR decreased COX2 and PTTG1 expression in UtLM cells. Our data support that UtLM and UtSM are immortalized cell lines without phenotypic alterations from parental cell types and suggest that COX2 and PTTG1 are molecular targets for BBR. However, studies in these cell lines may not reveal all activities of BBR in vivo, and we therefore proceeded to test in this report the antitumor effects of BBR in an UF nude mouse xenograft model. When UF nude mice were killed at 7 weeks, tumor weight in controls was 45 ± 7 mg versus 20 ± 3 mg (P <.05) in the low-dose (5 mg/kg) and 7 ± 3 mg (P <.01) in the high-dose (10 mg/kg) BBR groups, respectively. Expression of proliferation markers, cell cycle–related genes, and UF-related genes was downregulated in tumors. No unusual behavioral changes and no signs of kidney or liver damage were observed in the animals with BBR treatment. In conclusion, our data suggests that (a) COX2 and PTTG1 are molecular targets for BBR and (b) BBR is potentially an effective and safe anti-UF agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involve-ment on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010;25(2):418–429.

    Article  PubMed  Google Scholar 

  2. Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultra-sound CT MR. 2009;30(2):91–104.

    Article  Google Scholar 

  3. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1–9.

    Article  Google Scholar 

  4. Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current per-spectives. Int J Womens Health. 2014;6:95–114.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol. 2009;126(1):5–17.

    Article  CAS  PubMed  Google Scholar 

  6. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs. 2009;20(9):757–769.

    Article  CAS  PubMed  Google Scholar 

  7. Wu HL, Chuang TY, Al-Hendy A, Diamond MP, Azziz R, Chen YH. Berberine inhibits the proliferation of human uterine leio-myoma cells. Fertil Steril. 2015;103(4):1098–1106.

    Article  CAS  PubMed  Google Scholar 

  8. Ke X, Dou F, Cheng Z, et al. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):199–203.

    Article  CAS  PubMed  Google Scholar 

  9. Park SB, Jee BC, Kim SH, Cho YJ, Han M. Cyclooxygenase-2 inhibitor, celecoxib, inhibits leiomyoma cell proliferation through the nuclear factor kappaB pathway. Reprod Sci. 2014;21(9):1187–1195.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. J Clin Endocrinol Metab. 2005;90(6):3715–3723.

    Article  CAS  PubMed  Google Scholar 

  11. Fu L, Chen W, Guo W, et al. Berberine targets AP-2/hTERT, NF-kappaB/COX-2, HIF-lalpha/VEGF and cytochrome-c/Caspase signaling to suppress human cancer cell growth. PLoS One. 2013;8(7):e69240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Carney SA, Tahara H, Swartz CD, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest. 2002;82(6):719–728.

    Article  CAS  PubMed  Google Scholar 

  13. Hou YY, Cao WW, Li L, et al. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 2011;307(2):182–190.

    Article  CAS  PubMed  Google Scholar 

  14. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regula-tion. Ann Bot. 2011;107(7):1127–1140.

    Article  CAS  PubMed  Google Scholar 

  15. Doree M, Hunt T. From Cdc2 to Cdkl: when did the cell cycle kinase join its cyclin partner? J Cell Sci. 2002;115(Pt 12): 2461–2464.

    CAS  PubMed  Google Scholar 

  16. Fung TK, Ma HT, Poon RY. Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor. Mol Biol Cell. 2007;18(5):1861–1873.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the Gl cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995;92(18):8493–8497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between prolif-eration and cell death. Cancer Cell. 2008;13(1):11–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Qi HW, Xin LY, Xu X, Ji XX, Fan LH. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transi Med. 2014;12:22.

    Article  Google Scholar 

  20. Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433–2442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Chang YP, Huang CC, Shen CC, Tsai KC, Ueng YF. Differential inhibition of CYP1-catalyzed regioselective hydro-xylation of estradiol by berberine and its oxidative metabolites. Drug Metab Pharmacokinet. 2015;30(5):374–383.

    Article  CAS  PubMed  Google Scholar 

  22. Liu JP, Yang H, Xia Y, Cardini F. Herbal preparations for uterine fibroids. Cochrane Database Syst Rev. 2013;(4): CD005292.

    Google Scholar 

  23. Chen NN, Han M, Yang H, et al. Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids: a systematic review of randomised clinical trials. BMC Complement Altern Med. 2014;14:2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Roshdy E, Rajaratnam V, Maitra S, Sabry M, Allah AS, Al-Hendy A. Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study. Int J Womens Health. 2013;5:477–486.

    PubMed  PubMed Central  Google Scholar 

  25. Hodges LC, Houston KD, Hunter DS, et al. Transdominant sup-pression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Mol Cell Endocrinol. 2002; 196(1–2):11–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics/Gynecology, Augusta University, 1120 15th Street, CA-2020, Augusta, GA, 30912, USA

    Tung-Yueh Chuang PhD, Hsiao-Li Wu MS, MBA, Cristina McCrary BS, Lawrence C. Layman MD, Michael P. Diamond MD, Ricardo Azziz MD, MPH, MBA, Ayman Al-Hendy MD, PhD & Yen-Hao Chen PhD

  2. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Jie Min MD

Authors
  1. Tung-Yueh Chuang PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Min MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hsiao-Li Wu MS, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristina McCrary BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lawrence C. Layman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael P. Diamond MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ricardo Azziz MD, MPH, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ayman Al-Hendy MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yen-Hao Chen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yen-Hao Chen PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chuang, TY., Min, J., Wu, HL. et al. Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1. Reprod. Sci. 24, 1005–1013 (2017). https://doi.org/10.1177/1933719116675055

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116675055

Keywords

Search

Navigation